|
Dr. Pace has served as a director of the Company since December 2002. He is currently Chairman and Chief Executive Officer of QrxPharma Pty Ltd. a development stage biopharmaceutical company and a Visiting Scientist at the Massachusetts Institute of Technology (MIT). He also serves as a director of ResMed (NYSE:RMD) Transition Therapeutics Inc. (CDNX:TTH) Protiveris Inc. and CTour A/S. From 1995 to 2001 Dr. Pace was President and Chief Executive Officer of RTP Pharma and from 2000 to 2002 Dr. Pace was Chairman and Chief Executive Officer of Waratah Pharmaceuticals Inc. a spin-off company from RTP Pharma. From 1993 to 1994 he was the founding President and Chief Executive Officer of Transcend Therapeutics Inc. (formerly Free Radical Sciences Inc.) a biopharmaceutical company. From 1989 to 1993 he was Senior Vice President of Clintec International Inc. a Baxter/Nestle joint venture and manufacturer of clinical nutritional products. Dr. Pace holds a B.Sc. with honors from the University of New South Wales and a Ph.D. from MIT. | 